AstraZeneca admits it’s Covishield vaccine may lead to rare side effect
AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. According to media reports, the admission was made in a legal document submitted to the UK High Court in February. The company stated in the document that a rare… Continue reading "AstraZeneca admits it’s Covishield vaccine may lead to rare side effect"